Bradley Hayward, M.D.

Dr. Kaner is Associate Attending Physician at the NewYork-Presbyterian Weill Cornell Medical Center and Associate Professor of Clinical Medicine and Genetic Medicine at Weill Cornell Medicine. Dr. Kaner was the Principal Investigator of the Weill-Cornell Medicine site of the NIH-sponsored Idiopathic Pulmonary Fibrosis (IPF) Clinical Research Network for which he chaired the Adjudication Committee. He has extensive experience in the phenotyping of subjects with lung disease and their enrollment in research studies. He leads a monthly multidisciplinary ILD conference with Dr. William Travis (MSKCC) and Dr. Chen Zhang (WCM) for the past 15 years. He is the director of the New York Presbyterian Hospital – Weill Cornell Medicine Pulmonary Fibrosis Foundation Clinical Center of Excellence. He participates in clinical trials evaluating various pharmacologic interventions in IPF and other ILDs, sponsored by both NIH and pharma. He leads an ILD biobank, which enhances future translational research opportunities. He leads an observational study to determine the incidence and natural history of ILD following COVID-19 acute respiratory failure.Dr. Kaner chairs the bronchoscopy sub-study committee of the NHLBI SPIROMICS and SOURCE research networks, which uses RNA-sequencing to evaluate gene expression changes in lung cells associated with smoking and COPD endotypes. He is analyzing the effects of doxycycline on BAL matrix metalloproteinase (MMP) inhibition in HIV-positive individuals with early emphysema, based on his previous translational work. He is also participating in pharmacologic intervention studies in COPD and emphysema sponsored by the ALA, DOD and NIH, including leadership (with Dr. Marshall Glesby) of a Phase II multicenter trial of doxycycline to slow emphysema progression in PLWH. He is the Associate Director of the T32 training program and Associate Fellowship Program Director.

Emily Tonorezos, MD MPH is a Clinical Associate Professor of Medicine in the Division of Hematology and Medical Oncology at Weill Cornell Medicine/New York-Presbyterian Hospital. Dr. Tonorezos received her bachelor’s degree from Dartmouth College in Hanover, New Hampshire and her M.D. from the University of Rochester School of Medicine and Dentistry in 2001. Following Residency in Internal Medicine, she spent one year as Chief Resident in Internal Medicine, both at Columbia University Medical Center. She subsequently completed a General Internal Medicine fellowship at Johns Hopkins Hospital and Masters in Public Health at the Johns Hopkins Bloomberg School of Public Health. Dr. Tonorezos joined Weill Cornell from Memorial Sloan Kettering Cancer Center, where she served as Director of the Adult Long-Term Follow-Up Program for adult survivors of childhood and young adult cancers.

Dr. Tchang earned her medical degree from SUNY Downstate Medical Center. Dr. Tchang graduated with her BA from University of Chicago and was a NIH T32 trainee. She completed her residency at NewYork-Presbyterian/Weill Cornell , Endocrinology Diabetes & Metabolism Fellowship at NewYork-Presbyterian/Columbia University Irving Medical Center, and Obesity Fellowship at NewYork-Presbyterian/Weill Cornell . Dr. Tchang is board certified in Internal Medicine, Obesity Medicine, and Endocrinology, Diabetes & Metabolism.